ABO 血型不匹配的异基因干细胞移植后获得性纯红细胞再生障碍对大剂量地塞米松的反应。 - Suppr

Suppr

超能文献

Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation.

作者信息

Deotare U R, Vishwabandya A, Mathews V, George B, Srivastava A, Chandy M

出版信息

Bone Marrow Transplant. 2006 Jun;37(12):1149-50. doi: 10.1038/sj.bmt.1705378. Epub 2006 May 8.

DOI:10.1038/sj.bmt.1705378

PMID:16699532

Abstract

摘要

相似文献

Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation.ABO 血型不匹配的异基因干细胞移植后获得性纯红细胞再生障碍对大剂量地塞米松的反应。

Bone Marrow Transplant. 2006 Jun;37(12):1149-50. doi: 10.1038/sj.bmt.1705378. Epub 2006 May 8.

Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.通过诱导慢性移植物抗宿主病治疗主要ABO血型不合外周血干细胞移植后的纯红细胞再生障碍。

Bone Marrow Transplant. 2002 Oct;30(8):539-41. doi: 10.1038/sj.bmt.1703699.

[Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].[ABO血型不合造血干细胞异体移植后纯红细胞再生障碍性贫血]

Medicina (B Aires). 2002;62(6):575-7.

Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.采用递增剂量供体白细胞输注治疗的主要ABO血型不合异基因干细胞移植后发生的难治性纯红细胞再生障碍性贫血

Eur J Haematol. 2004 Dec;73(6):441-6. doi: 10.1111/j.1600-0609.2004.00320.x.

Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.低强度预处理后ABO血型不合对异基因外周血造血干细胞移植的影响。

Transfusion. 2004 Nov;44(11):1603-11. doi: 10.1111/j.1537-2995.2004.04106.x.

Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.在主要ABO血型不相合的异基因外周血祖细胞移植前进行供者型红细胞输注的安全性及影响

Transfusion. 2005 Oct;45(10):1676-83. doi: 10.1111/j.1537-2995.2005.00578.x.

[ABO incompatibility and non myeloablative allogeneic stem cell transplantation].[ABO血型不相容与非清髓性异基因干细胞移植]

Transfus Clin Biol. 2007 Aug;14(3):327-33. doi: 10.1016/j.tracli.2007.03.002. Epub 2007 Apr 25.

Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.间充质干细胞用于治疗主要ABO血型不合造血干细胞移植后的难治性纯红细胞再生障碍性贫血。

Ann Hematol. 2009 Mar;88(3):261-6. doi: 10.1007/s00277-008-0599-0. Epub 2008 Sep 4.

Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.主要和双向ABO血型不相合的异基因干细胞移植后发生的纯红细胞再生障碍：采用不同治疗策略长期治疗后供体来源红细胞生成的恢复

Ann Hematol. 2007 Sep;86(9):677-83. doi: 10.1007/s00277-007-0304-8. Epub 2007 May 8.

Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.在一名儿童因获得性再生障碍性贫血接受主要ABO血型不相合外周血异基因干细胞移植后，单剂量利妥昔单抗成功治疗纯红细胞再生障碍。

Bone Marrow Transplant. 2002 Sep;30(6):405-7. doi: 10.1038/sj.bmt.1703668.

引用本文的文献

Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation.使用Glycosorb® ABO免疫吸附系统进行抗原特异性免疫吸附作为主要和双向ABO血型不合异基因造血干细胞移植后纯红细胞再生障碍的一种新型治疗方式

Front Med (Lausanne). 2020 Oct 22;7:585628. doi: 10.3389/fmed.2020.585628. eCollection 2020.

Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.主要或双向 ABO 不相容造血干细胞移植后纯红细胞再生障碍：治疗还是不治疗，这是个问题。

Bone Marrow Transplant. 2021 Apr;56(4):769-778. doi: 10.1038/s41409-020-01124-6. Epub 2020 Nov 14.

Oral High Dose Dexamethasone for Pure Red Cell Aplasia Following ABO-Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report.口服高剂量地塞米松治疗ABO血型不合异基因外周血干细胞移植后纯红细胞再生障碍：一例报告

Indian J Hematol Blood Transfus. 2015 Jun;31(2):317-8. doi: 10.1007/s12288-013-0276-x. Epub 2013 Jun 9.

Pulsed-high-dose dexamethasone as a treatment for pure red cell aplasia following ABO-incompatible allogeneic stem cell transplantation.脉冲高剂量地塞米松治疗ABO血型不合异基因造血干细胞移植后纯红细胞再生障碍性贫血

Transfus Med. 2014 Aug;24(4):246-8. doi: 10.1111/tme.12143.

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation.利妥昔单抗成功治疗ABO血型相合异基因造血干细胞移植术后患者的纯红细胞再生障碍性贫血

Case Rep Oncol. 2012 Jan;5(1):110-3. doi: 10.1159/000337022. Epub 2012 Feb 29.

Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.通过移植前降低宿主抗供体同种凝集素预防主要或双向ABO血型不相合造血干细胞移植后的纯红细胞再生障碍。

Haematologica. 2009 Feb;94(2):239-48. doi: 10.3324/haematol.13356. Epub 2009 Jan 14.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验